Viracta Therapeutics Inc (VIRX)
0.2003
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
0.2003
0.00 (0.00%)
After-Hours: 19:06
Viracta Therapeutics Shareholders Equity (Quarterly): 2.671M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.671M |
| March 31, 2024 | 11.08M |
| December 31, 2023 | 18.32M |
| September 30, 2023 | 30.01M |
| June 30, 2023 | 40.78M |
| March 31, 2023 | 51.11M |
| December 31, 2022 | 61.10M |
| September 30, 2022 | 67.81M |
| Date | Value |
|---|---|
| June 30, 2022 | 77.00M |
| March 31, 2022 | 85.60M |
| December 31, 2021 | 94.37M |
| September 30, 2021 | 103.98M |
| June 30, 2021 | 117.10M |
| March 31, 2021 | 124.74M |
| December 31, 2020 | -46.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-46.20M
Minimum
Dec 2020
124.74M
Maximum
Mar 2021
55.97M
Average
61.10M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Arbutus Biopharma Corp | 122.45M |
| GlycoMimetics Inc | 20.06M |
| FibroGen Inc | -232.34M |
| Cidara Therapeutics Inc | 130.94M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.32M |
| Total Liabilities (Quarterly) | 28.65M |